Exhibitor Information

Make your mark by exhibiting at the 34th Annual Meeting & Pre-Conference Programs (SITC 2019). This event brings together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education, scientific exchange and networking with the scientists driving the field.

SITC's 2019 Exhibit Hall is currently full. Please contact development@sitcancer.org to be placed on a waiting list.

Download the 2019 Exhibitor Prospectus

For information about exhibiting or other ways to support SITC, contact the Development Office at (414) 271-2456 or development@sitcancer.org.

SITC does not partner with third party vendors on mailing lists or housing, and any meeting registrations should originate from sitcancer.org. We do work with Showcare Event Solutions for our registration needs, so communications that come from SITC@showcare.com or LEADS@showcare.com are legitimate.

Click to download the 2019 Exhibitor Prospectus


Contact the Development Office at (414) 271-2456 or development@sitcancer.org for more information on exhibit and support opportunities.

Important Exhibitor Dates

The following are important dates for organizations considering exhibiting at SITC 2019:

Sept. 6, 2019

Exhibit Booth Reservation Deadline

Oct. 8, 2019

Discounted Early Registration Deadline

Oct. 14, 2019

Housing Reservation Deadline

Nov. 7, 2019

Exhibitor Move-In

Nov. 9, 2019

Exhibitor Move-Out

Who Exhibits at SITC?

  • Biotechnology companies
  • Cancer organizations and foundations
  • Consulting groups
  • Data management companies
  • Informatics/analysis firms
  • Medical device manufacturers
  • Medical equipment suppliers
  • Medical publishers
  • Pharmaceutical companies
  • Research companies/agencies
  • Scientific supply companies
  • Universities, hospitals and research institutions

Why Exhibit at SITC?

SITC is the preferred meeting in cancer immunotherapy by leading immunologists, academicians and researchers in the field. SITC 2019 exhibitors are able to:

  • Meet thought leaders in cancer immunotherapy from around the globe
  • Interact with key investigators and clinicians who evaluate and purchase your products or services
  • Gain insight into new and innovative uses of your products or services by speaking to experts at the forefront of the science
  • Generate new leads
  • Achieve sales and business development objectives